Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
alfuzosin alpha-1 adrenergic receptors small molecule NA drugbank , DGIDB Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.38 approved,investigational antagonist
alfuzosin alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.38 approved,investigational antagonist
alfuzosin alpha-1 adrenergic receptors small molecule NA drugbank , DGIDB Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.63 approved,investigational antagonist
alfuzosin alpha-1b adrenergic receptor small molecule NA drugbank , DGIDB Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.63 approved,investigational antagonist
alfuzosin alpha-1 adrenergic receptors small molecule NA drugbank , DGIDB Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.71 approved,investigational antagonist
alfuzosin alpha-1d adrenergic receptor small molecule NA drugbank , DGIDB Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.71 approved,investigational antagonist
alfuzosin adrenergic receptor alpha-1d NA Successful target TTD , DGIDB Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.71 approved unknown
alfuzosin adrenergic receptor alpha-1d NA Successful target TTD , DGIDB Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.71 approved antagonist
click here to return to the previous page